Role : SAP ATTP
Location : Normal, IL – 5 days onsite
Contract : Long-term
Roles & Responsibilities:
- SAP ATTP (Advanced Track & Trace for Pharmaceuticals) Solution Architect to lead the design, implementation, and continuous improvement of serialization and pharmaceutical compliance systems across global supply chain for a MedTech Customer
- Lead the architectural design, configuration, and governance of SAP ATTP solutions, ensuring alignment with business and compliance requirements.
- Hands on experience with SAP ATTP implementations and end to end serialization deployments in the pharmaceutical industry.
- Mandatory Upgrade 1-2 Project implementation/upgrade experience on ATTP from NetWeaver (STTP 3xx) to ATTP on S/4HANA Cloud Foundation
- Develop solution blueprints, integration patterns, and end to end serialization process flows across supply chain, packaging, warehouse, and distribution environments.
- Own SAP ATTP configuration activities including Rules, GCP settings, Serialization Profiles, GTIN setups, and related master/transaction data elements.
- Drive full lifecycle implementation activities—requirements gathering, configuration, FIT/GAP analysis, documentation, testing, validation, and deployment
Ensure robust, compliant integration between SAP ATTP and:
- SAP S/4HANA
- SAP WM/EWM
- Packaging line systems (Systech, OPTEL, PCE, Pharma Proof, LineMaster)
- ICH/trading partner serialization platforms
- Excellent communication skills with the ability to collaborate across manufacturing, supply chain, QA, IT, and external partners.
|
Arjun BHATT |
E: arjun.b@noviainfotech.com M: (972) 961 2004 Linkedin: linkedin.com/in/arjun-bhatt-3a86001b5 |
You received this message because you are subscribed to the Google Groups "NoviaJobs" group.
To unsubscribe from this group and stop receiving emails from it, send an email to noviajobs+unsubscribe@googlegroups.com.
To view this discussion visit https://groups.google.com/d/msgid/noviajobs/CANVQszGnYEYDUVW2_173Wfeg2S%3D%2BnUfDA3%3DVm3v_m_BfRR%2BAfA%40mail.gmail.com.
No comments:
Post a Comment